Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Coping with Self-Harm: A Guide for Parents and Carers, developed by the University of Oxford’s Centre for Suicide Research has been recognised in the BMA Patient Information Awards.

Team from Centre for Suicide Research © Department of Psychiatry

A team of academics and clinicians, led by those at the University of Oxford and Oxford Health NHS Foundation Trust have collaborated to produce a guide which was ‘Highly Commended’ at the recent BMA Patient information awards.

Read more ..

Pictured left to right to receive the commendation: Fiona Brand, Psychiatric Liaison Nurse/Research Nurse, Oxford Health NHS Foundation Trust; Anne StewartFRCPsych, Central Oxon CAMHS, Oxford Health NHS Foundation Trust and University of Oxford, Anne Ferrey, Research Coordinator, University of Oxford Centre for Suicide Research; Keith Hawton, Director of the Centre for Suicide Research, University of Oxford; Sue Simkin, former research coordinator, Centre for Suicide Research; Nic HughesSenior Research Fellow in Palliative Care & Lecturer in Nursing, University of Leeds; and Liz Bale, Research Assistant, Oxford Centre for Suicide Research.

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.